New developments in the diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome

Current Opinion in Urology

Volumn 23, Issue 6, 2013, Pages 565-569

  Pontari, Michel ^a   Giusto, Laura ^a  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

chronic pelvic pain syndrome; neuropathic pain; prostatitis

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBODY; BIOLOGICAL MARKER; PREGABALIN; TENAZUMAB; UNCLASSIFIED DRUG;

ACUPUNCTURE; ARTICLE; AUTOIMMUNE DISEASE; BACTERIUM; CHRONIC FATIGUE SYNDROME; CHRONIC PAIN; CHRONIC PROSTATITIS; CLINICAL TRIAL; DIABETIC NEUROPATHY; FIBROMYALGIA; HUMAN; IRRITABLE COLON; MEDIATOR; NEUROGENIC INFLAMMATION; NEUROPATHIC PAIN; PELVIS FLOOR; PELVIS PAIN SYNDROME; PHYSIOTHERAPY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; SKELETAL MUSCLE; SOCIAL ASPECT;

ADRENERGIC ALPHA-ANTAGONISTS; CHRONIC DISEASE; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; PELVIC PAIN; PROSTATITIS; PSYCHOLOGICAL TECHNIQUES; SYNDROME; TREATMENT OUTCOME;

EID: 84885480907     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3283656a55     Document Type: Article

References (40)

1. Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. J Am Med Assoc 1999; 282:236-237. (Pubitemid 29343164)
2. Pontari M. Chronic prostatitis/chronic pelvic pain: the disease. J Urol 2009; 182:19-20.
3. Shoskes DA. The challenge of erectile dysfunction in the man with chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 2012; 13:263-267.
4. Chung SD, Keller JJ, Lin HC. A case-control study on the association between chronic prostatitis/chronic pelvic pain syndrome and erectile dysfunction. BJU Int 2012; 110:726-730.
5. Shoskes DA, Nickel JC, Rackley RR, Pontari MA. Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer Prostatic Dis 2009; 12:177-183.
6. Samplaski MK, Li J, Shoskes DA. Clustering of UPOINT domains and subdomains in men with chronic prostatitis/chronic pelvic pain syndrome and contribution to symptom severity. J Urol 2012; 188:1788-1793.
7. Rodriguez MA, Afari N, Buchwald DS. National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Urological Chronic Pelvic Pain: evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol 2009; 182:2123-2131.
8. Christianson JA, Liang R, Ustinova EE, et al. Convergence of bladder and colon sensory innervation occurs at the primary afferent level. Pain 2007; 128:235-243. (Pubitemid 46367418)
9. Ustinova EE, Fraser MO, Pezzone MA. Cross-talk and sensitization of bladder afferent nerves. Neurourol Urodyn 2010; 29:77-81.
10. Pezet S, McMahon SB. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 2006; 29:507-538. (Pubitemid 44476854)
11. Watanabe T, InoueM, Sasaki K, et al. Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. BJU Int 2011; 108:248-251.
12. Miller LJ, Fischer KA, Goralnick SJ, et al. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 2002; 59:603-608. (Pubitemid 34249905)
13. Kouiavskaia DV, Southwood S, Berard CA, et al. T-cell recognition of prostatic peptides in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol 2009; 182:2483-2489.
14. Chapoval AI, Ni J, Lau JS, et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2001; 2:269-274. (Pubitemid 33706005)
15. Castriconi R, Dondero A, Augugliaro R, et al. Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis. Proc Natl Acad Sci USA 2004; 101:12640-12645. (Pubitemid 39122076)
16. Wei X, Zhang G, Yuan H, et al. Detection and quantitation of soluble B7-H3 in expressed prostatic secretions: a novel marker in patients with chronic prostatitis. J Urol 2011; 185:532-537.
17. Breser ML,Motrich RD, Sanchez LR, et al. Expression of CXCR3 on specific T cells is essential for homing to the prostate gland in an experimental model of chronic prostatitis/chronic pelvic pain syndrome. J Immunol 2013; 190:3121-3133.
18. Pontari MA, McNaughton-Collins M, O'leary MP, et al. CPCRN Study G: a case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int 2005; 96:559-565. (Pubitemid 41224327)
19. Shoskes DA, Prots D, Karns J, et al. Greater endothelial dysfunction and arterial stiffness in men with chronic prostatitis/chronic pelvic pain syndrome: a possible link to cardiovascular disease. J Urol 2011; 186:907-910.
20. Anderson RU, Sawyer T, Wise D, et al. Painful myofascial trigger points and pain sites in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol 2009; 182:2753-2758.
21. Khorasani B, Arab AM, Sedighi Gilani MA, et al. Transabdominal ultrasound measurement of pelvic floor muscle mobility in men with and without chronic prostatitis/chronic pelvic pain syndrome. Urology 2012; 80:673-677.
22. Shoskes DA, Nickel JC, Kattan MW. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology 2010; 75:1249-1253.
23. Nickel JC, O'Leary MP, Lepor H, et al. Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study. J Urol 2011; 186:125-131.
24. Oelke M, Giuliano F, Mirone V, et al. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. Eur Urol 2012; 61:917-925.
25. Grimsley SJ, Khan MH, Jones GE. Mechanism of phosphodiesterase 5 inhibitor relief of prostatitis symptoms. Med Hypotheses 2007; 69:25-26. (Pubitemid 46686963)
26. Chung SD, Huang CC, Lin HC. Chronic prostatitis and depressive disorder: a three year population-based study. J Affect Disord 2011; 134:404-409.
27. Nickel JC, Mullins C, Tripp DA. Development of an evidence-based cognitive behavioral treatment program for men with chronic prostatitis/chronic pelvic pain syndrome. World J Urol 2008; 26:167-172.
28. Ginting JV, Tripp DA, Nickel JC. Self-reported spousal support modifies the negative impact of pain on disability in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2011; 78:1136-1141.
29. Nickel JC, Roehrborn C, Montorsi F, et al. Dutasteride reduces prostatitis symptoms compared with placebo in men enrolled in the REDUCE study. J Urol 2011; 186:1313-1318.
30. Gao M, Ding H, Zhong G, et al. The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and post-treatment. Urology 2012; 79:391-396.
31. Anothaisintawee T, Attia J, Nickel JC, et al. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. J Am Med Assoc 2011; 305:78-86.
32. Weinstock LB, Geng B, Brandes SB. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin. Can J Urol 2011; 18:5826-5830.
33. Boyle J, Eriksson ME, Gribble L, et al. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diab Care 2012; 35:2451-2458.
34. Pontari MA, Krieger JN, Litwin MS, et al. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med 2010; 170:1586-1593.
35. Nickel JC, Atkinson G, Krieger JN, et al. Preliminary assessment of safety and efficacy in proof-of-concept, randomized clinical trial of tanezumab for chronic prostatitis/chronic pelvic pain syndrome. Urology 2012; 80:1105-1110.
36. Lee SW, Liong ML, Yuen KH, et al. Validation of a sham acupuncture procedure in a randomised, controlled clinical trial of chronic pelvic pain treatment. Acupunct Med 2011; 29:40-46.
37. Lee SH, Lee BC. Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three-arm randomized trial. Urology 2009; 73:1036-1041.
38. Posadzki P, Zhang J, Lee MS, Ernst E. Acupuncture for chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a systematic review. J Androl 2012; 33:15-21.
39. Anderson RU, Wise D, Sawyer T, Chan C. Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J Urol 2005; 174:155-160. (Pubitemid 40825701)
40. Fitzgerald MP, Anderson RU, Potts J, et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol 2013; 189:S75-85.